[Clinical experience with bactrim therapy mainly in childhood urinary tract infections].
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D005493:Folic Acid Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D008297:Male; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*; D011776:Pyuria / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced
D005493:Folic Acid Antagonists; D011743:Pyrimidines; D013420:Sulfamethoxazole
Klinische Erfahrungen mit der Bactrim-Therapie vorwiegend bei Harnwegsinfektionen im Kindesalter.